OpenVSafe by OpenVAERS
Search V-safe

YSY-64097-96549

2 vaccinations 2 coded responses 15 check-ins 2 free-text entries 1 call case
Sex
Male
Age at first dose
05-11
ZIP prefix
223 / VA
Registered
2021-12-01
Relationship
Child or adolescent in my care
Guardian
SUA-27849-65536
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-11-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-30
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-01
    Registered in v-safe
  4. 2021-12-01
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-12-02
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-12-03
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-12-04
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-12-05
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  9. 2021-12-06
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  10. 2021-12-07
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  11. 2021-12-14
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2021-12-21
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2021-12-28
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  14. 2022-01-04
    Survey response — day 35, dose 2, dependent
    MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Congestion, runny nose, cough, sneezing
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-01-11
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  16. 2022-03-03
  17. 2022-05-31
  18. 2022-11-30
    Survey response — 12 months, dose 2, dependent
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-11-30
    Report sent to call center — 12 months, dose 2, dependent
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  20. 2022-12-01

Vaccinations

DoseDateManufacturerCo-administered
12021-11-06Pfizer-BioNTech No
22021-11-30Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — day 35, dose 2, dependent

2022-01-04

Symptoms: Congestion, runny nose, cough, sneezing

Release 12 — 12 months, dose 2, dependent

2022-11-30

Symptoms: Cold symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDNasopharyngitis · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SDSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release